Koers Acerus Pharmaceuticals Corporation Toronto S.E.
Aandelen
ASP
CA00444G4051
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01-05-18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09-09-13 |
Borys Chabursky
BRD | Director/Board Member | - | 20-12-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |